1. Chen, Jingyu, Zhang, Zizhen, Ni, Jiaojiao, Wang, Liangjing, Xue, Meng. 2022. ENO3 promotes colorectal cancer progression by enhancing cell glycolysis. In Medical oncology (Northwood, London, England), 39, 80. doi:10.1007/s12032-022-01676-1. https://pubmed.ncbi.nlm.nih.gov/35477821/
2. Cui, Honglei, Guo, Danfeng, Zhang, Xiaodan, Guo, Wenzhi, Zhang, Shuijun. 2021. ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway. In Frontiers in cell and developmental biology, 9, 797102. doi:10.3389/fcell.2021.797102. https://pubmed.ncbi.nlm.nih.gov/35004693/
3. Isgrò, Maria Antonietta, Bottoni, Patrizia, Scatena, Roberto. . Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. In Advances in experimental medicine and biology, 867, 125-43. doi:10.1007/978-94-017-7215-0_9. https://pubmed.ncbi.nlm.nih.gov/26530364/
4. Wang, Yuanyuan, Zhao, Xue, Zhang, Liuchao, Qin, Jian, Chu, Xia. 2023. MicroRNA-34a Mediates High-Fat-Induced Hepatic Insulin Resistance by Targeting ENO3. In Nutrients, 15, . doi:10.3390/nu15214616. https://pubmed.ncbi.nlm.nih.gov/37960269/
5. Lu, Di, Xia, Qiaoyun, Yang, Zhiyu, Li, Xiuling, Cao, Mingbo. . ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation. In Annals of translational medicine, 9, 661. doi:10.21037/atm-21-471. https://pubmed.ncbi.nlm.nih.gov/33987359/
智鼠故事 
